These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21055849)

  • 1. [Biotherapies to treat necrotizing vasculitis].
    Guillevin L
    Rev Med Interne; 2010 Dec; 31 Suppl 3():S304-6. PubMed ID: 21055849
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic strategies for systemic necrotizing vasculitides.
    Guillevin L; Pagnoux C
    Allergol Int; 2007 Jun; 56(2):105-11. PubMed ID: 17460440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory and/or severe ANCA-associated systemic necrotizing vasculitides.
    Guillevin L; Pagnoux C
    Isr Med Assoc J; 2008 Jan; 10(1):89-91. PubMed ID: 18300585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Off-label use of biological therapies in systemic diseases].
    Hachulla E
    Rev Med Interne; 2010 Dec; 31 Suppl 3():S307-14. PubMed ID: 21036424
    [No Abstract]   [Full Text] [Related]  

  • 5. [Twenty-seven years' activities of the French vasculitis study group (FVSG)].
    Guillevin L
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S263-5. PubMed ID: 18029060
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological therapies: new treatment options for ANCA-associated vasculitis?
    Aries PM; Lamprecht P; Gross WL
    Expert Opin Biol Ther; 2007 Apr; 7(4):521-33. PubMed ID: 17373903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the use of biologic agents for the treatment of systemic vasculitis.
    Chung SA; Seo P
    Curr Opin Rheumatol; 2009 Jan; 21(1):3-9. PubMed ID: 19077713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapies in dermatologic disorders.
    Fallen RS; Terpstra CR; Lima HC
    Med Clin North Am; 2012 May; 96(3):565-82, x-xi. PubMed ID: 22703856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept.
    Weinberg JM; Saini R
    Cutis; 2003 Jan; 71(1):25-9. PubMed ID: 12553627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary affectation of vasculitis.
    Martín-Suñé N; Ríos-Blanco JJ
    Arch Bronconeumol; 2012 Nov; 48(11):410-8. PubMed ID: 22682604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasculitis: update 2014].
    Fleck M; Aries PM; Iking-Konert C
    Dtsch Med Wochenschr; 2014 Jun; 139(23):1234-6. PubMed ID: 24866957
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vasculitis].
    Fleck M; Hellmich B
    Dtsch Med Wochenschr; 2011 Jun; 136(22):1194-6. PubMed ID: 21611928
    [No Abstract]   [Full Text] [Related]  

  • 13. Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
    Flossmann O; Jones RB; Jayne DR; Luqmani RA
    Ann Rheum Dis; 2006 Jul; 65(7):841-4. PubMed ID: 16769779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary systemic vasculitis: treatment of difficult cases.
    Foster R; Rosenthal E; Marques S; Vounotrypidis P; Sangle S; D'Cruz D
    Lupus; 2006; 15(3):143-7. PubMed ID: 16634367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.
    Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the treatments of systemic vasculitides.
    Guillevin L
    Clin Rev Allergy Immunol; 2008 Oct; 35(1-2):72-8. PubMed ID: 18181034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [[Treatment of therapy resistant pemphigus vulgaris with rituximab and immunoglobulins].
    Mühlhoff C; Megahed M
    Hautarzt; 2007 Nov; 58(11):924-6. PubMed ID: 17952393
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis.
    Cohen C; Mekinian A; Saidenberg-Kermanac'h N; Stirnemann J; Fenaux P; Gherardi R; Fain O
    Ann Rheum Dis; 2012 Apr; 71(4):628-9. PubMed ID: 22121135
    [No Abstract]   [Full Text] [Related]  

  • 19. [CME. Biologics in vasculitis].
    Scharl M; Schaer D; Vallelian F
    Praxis (Bern 1994); 2015 Jan; 104(1):7-16; quiz 15. PubMed ID: 25552441
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of primary systemic necrotizing vasculitides: the role of biotherapies.
    Guillevin L
    Clin Exp Nephrol; 2013 Oct; 17(5):622-627. PubMed ID: 24018402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.